{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:06:42Z","timestamp":1779858402978,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xphs.2025.103976","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:14:18Z","timestamp":1756397658000},"page":"103976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the influence of mucus layer, bile acids, and pharmaceutical excipients on the intestinal permeability of solifenacin using PermeaPad\u2122 plate"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6841-5601","authenticated-orcid":false,"given":"Yuki","family":"Hagiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2027-2017","authenticated-orcid":false,"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2025.103976_bib0001","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2014.03.017","article-title":"A tunable Caco-2\/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure","volume":"87","author":"B\u00e9duneau","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0002","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/acs.molpharmaceut.6b01165","article-title":"Usefulness of Caco-2\/HT29-MTX and Caco-2\/HT29-MTX\/Raji B coculture models to predict intestinal and colonic permeability compared to Caco-2 monoculture","volume":"14","author":"Lozoya-Agullo","year":"2017","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0003","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dmpk.2020.04.334","article-title":"Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells","volume":"35","author":"Kabeya","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"issue":"6","key":"10.1016\/j.xphs.2025.103976_bib0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/2472630320924999","article-title":"An Intestine-on-a-chip model of plug-and-play modularity to study inflammatory processes","volume":"25","author":"Gijzen","year":"2020","journal-title":"SLAS Technol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78359-2","article-title":"Development of a human primary gut-on-a-chip to model inflammatory processes","volume":"10","author":"Beaurivage","year":"2020","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.xphs.2025.103976_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144964","article-title":"Direct on-chip differentiation of intestinal tubules from induced pluripotent stem cells","volume":"21","author":"Naumovska","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0007","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jcmgh.2017.12.008","article-title":"Enhanced utilization of induced pluripotent stem cell\u2013Derived Human intestinal organoids using microengineered chips","volume":"5","author":"Workman","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/cts.13132","article-title":"Microphysiological systems in absorption, distribution, metabolism, and elimination sciences","volume":"15","author":"Van Ness","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040721","article-title":"Modulation of paracellular-like drug transport across an artificial biomimetic barrier by osmotic stress-induced liposome shrinking","volume":"14","author":"Eriksen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103976_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejpb.2019.07.013","article-title":"Intestinal absorption-modifying excipients: a current update on preclinical in vivo evaluations","volume":"142","author":"Dahlgren","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.103976_bib0011","article-title":"In vitro dissolution\/permeation tools for amorphous solid dispersions bioavailability forecasting II: comparison and mechanistic insights","volume":"188","author":"Nunes","year":"2023","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2025.103976_bib0012","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.3390\/molecules200814451","article-title":"Absorption-enhancing effects of bile salts","volume":"20","author":"Moghimipour","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2025.103976_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124727","article-title":"Comparison of in vitro screening methods for evaluating the effects of pharmaceutical excipients on membrane permeability","volume":"665","author":"Morita","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103976_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2018.04.016","article-title":"Drug permeability profiling using cell-free permeation tools: overview and applications","volume":"119","author":"Berben","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2015.07.028","article-title":"Permeapad\u2122 for investigation of passive drug permeability: the effect of surfactants, co-solvents and simulated intestinal fluids (FaSSIF and FeSSIF)","volume":"493","author":"Bibi","year":"2015","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2025.103976_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050227","article-title":"High-throughput dissolution\/permeation screening\u2014A 96-well two-compartment microplate approach","volume":"11","author":"Jacobsen","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.xphs.2025.103976_bib0017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11095-020-02807-x","article-title":"Drug permeability profiling using the novel Permeapad\u00ae 96-well plate","volume":"37","author":"Jacobsen","year":"2020","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2025.103976_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020380","article-title":"Permeability assessment of a high-throughput mucosal platform","volume":"15","author":"Butnarasu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xphs.2025.103976_bib0019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200948050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of Solifenacin","volume":"48","author":"Doroshyenko","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5599\/admet.4.4.338","article-title":"Investigation of biopharmaceutical and physicochemical drug properties suitable for orally disintegrating tablets","volume":"4","author":"Ono","year":"2016","journal-title":"ADMET DMPK"},{"issue":"6","key":"10.1016\/j.xphs.2025.103976_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.684","article-title":"Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity","volume":"8","author":"Tannenbaum","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.xphs.2025.103976_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105107","article-title":"The mechanism of solifenacin release from a pH-responsive ion-complex oral suspension in the fasted upper gastrointestinal lumen","volume":"142","author":"Yamamoto","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.xphs.2021.11.016","article-title":"A novel In vitro membrane permeability methodology using three-dimensional caco-2 tubules in a microphysiological system which better mimics In vivo physiological conditions","volume":"111","author":"Hagiwara","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103976_bib0024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040699","article-title":"Mucin-protected Caco-2 assay to study drug permeation in the presence of complex biorelevant Media","volume":"14","author":"Ye","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2017.12.038","article-title":"Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): an artificial permeability tool for drug screening and formulation development","volume":"537","author":"Falavigna","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2025.103976_bib0028","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1021\/acs.molpharmaceut.3c00550","article-title":"Bile is a selective elevator for mucosal mechanics and transport","volume":"20","author":"Hanio","year":"2023","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2025.103976_bib0029","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in Human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys J"},{"key":"10.1016\/j.xphs.2025.103976_bib0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","article-title":"A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption","volume":"57","author":"Augustijns","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2025.103976_bib0031","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution Media simulating conditions in the proximal Human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2025.103976_bib0032","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1208\/s12248-012-9337-6","article-title":"The solubility\u2013permeability interplay and its implications in formulation design and development for poorly soluble drugs","volume":"14","author":"Dahan","year":"2012","journal-title":"AAPS J"},{"issue":"44","key":"10.1016\/j.xphs.2025.103976_bib0033","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1021\/j100095a040","article-title":"Stepwise self-association of sodium taurocholate and taurodeoxycholate As revealed by chromatography","volume":"98","author":"Funasaki","year":"1994","journal-title":"J Phys Chem"},{"issue":"1","key":"10.1016\/j.xphs.2025.103976_bib0034","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/la00091a030","article-title":"Critical micelle concentration behavior of sodium taurocholate in water","volume":"6","author":"Meyerhoffer","year":"1990","journal-title":"Langmuir"},{"key":"10.1016\/j.xphs.2025.103976_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114283","article-title":"Adsorption of bile salts onto crystalline ritonavir particles under simulated gastrointestinal conditions","volume":"245","author":"Aljabbari","year":"2025","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"2","key":"10.1016\/j.xphs.2025.103976_bib0036","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/gast.1996.v110.pm8566593","article-title":"Intestinal absorption of bile acids in the rabbit: different transport rates in jejunum and ileum","volume":"110","author":"Aldini","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xphs.2025.103976_bib0037","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile Acid physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann Hepatol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:50:09Z","timestamp":1779857409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022354925004307"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103976","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the influence of mucus layer, bile acids, and pharmaceutical excipients on the intestinal permeability of solifenacin using PermeaPad\u2122 plate","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103976"}}